Better U.S. Patient Access To Cancer Drugs Comes At A Price

Comparing the U.S. and the European Union, where do patients have greater access to cancer drugs? This question isn’t as easy to answer as it would seem. Patient access to pharmaceuticals is multidimensional; the two main dimensions being the regulatory framework and pricing and reimbursement.